Moreover, the identification of a woman harboring a rare mutation, who remained dementia-free despite extensive Aβ deposition but minimal Tau pathology, underscores the emerging concept that aberrant Tau may represent a pivotal etiological factor in AD [52]. This evidence concerns the gene MAPT and Alzheimer disease.